Risk-adapted therapy guided by human papillomavirus (HPV) circulating tumor DNA in HPV-positive oropharyngeal cancer (ReACT 1.0): an exploratory phase II trial

Glenn J. Hanna

Tulika R. Gupta

Lorenzo Trippa

From Médecins Sans Frontières (L.G., F.V.), Sorbonne Université, INSERM Unité 1135, Centre d’Immunologie et des Maladies Infectieuses (L.G.), Assistance Publique–Hôpitaux de Paris, Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié–Salpêtrière, Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux (L.G.), and Epicentre (M.G., E. Baudin), Paris, and Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier Université de Montpellier, Montpellier, Institut de Recherche pour le Développement, Montpellier, INSERM, Montpellier (M.B.) — all in France; Interactive Development and Research, Singapore (U.K.); McGill University, Epidemiology, Biostatistics, and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis (G.E.V., P.N., P.P.J.P.) and the Division of HIV, Infectious Diseases, and Global Medicine (G.E.V.), University of California at San Francisco, San Francisco; the National Scientific Center of Phth...

Eleni M. Rettig

Danielle N. Margalit

Roy B. Tishler

Itai Pashtan

Emily Kim

Alexander Droznin

Lauren Gunasti

Riley Maddox

Jacqueline Minken

Dev Mukundan

Kartik Sehgal

Michael J. Dennis

Thomas O’Connor

Jack M. Qian

Graham H. Boyd

Anurag Saraf

Daribelle Massiel Gil

Rosh K. Sethi

Donald J. Annino

Lauren A. Goguen

Jeffrey P. Guenette

Mina Bakhtiar

Vickie Y. Jo

Kristine Wong

Ravindra Uppaluri

Robert I. Haddad

Jonathan D. Schoenfeld